WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--Kylin Therapeutics Inc. announces its newest member to serve on its board of directors - a retired Eli Lilly and Co. executive. Homer L. Pearce, a retired distinguished research fellow and former Lilly vice president of cancer research and clinical investigation, joined the Kylin board of directors.
